*  Influenza research
Vaccine production capacity: The protective immune response generated by current influenza vaccines is largely based on viral ... hepatitis B, polio, measles and smallpox. HHS Secretary Mike Leavitt announced on January 4, 2007 that the Department has ... In contrast, cell culture manufacturing technology can be applied to influenza vaccines as they are with most viral vaccines (e ... to influenza vaccines as they are with most viral vaccines and thereby solve the problems associated with creating flu vaccines ...
*  HBsAg
... hepatitis B vaccine in the 1980s, was made from HBsAg extracted from the blood plasma of hepatitis patients. Current vaccines ... It is present in the sera of patients with viral hepatitis B (with or without clinical symptoms). Patients who developed ... It indicates current hepatitis B infection. The viral envelope of an enveloped virus has different surface proteins from the ... It was discovered to be part of the virus that caused serum hepatitis by virologist Alfred Prince in 1968. Heptavax, a "first- ...
*  Viral hepatitis
A vaccine is available that will prevent infection from hepatitis B for life. Hepatitis B infections result in 500,000 to ... The most common causes of viral hepatitis are the five unrelated hepatotropic viruses hepatitis A, hepatitis B, hepatitis C, ... In 2013 about 1.5 million people died from viral hepatitis. Most deaths are due to hepatitis B and hepatitis C. East Asia is ... Hepatitis B is caused by hepatitis B virus, a hepadnavirus that can cause both acute and chronic hepatitis. Chronic hepatitis ...
*  Hepatitis C vaccine
Randal, J. (1999). "Hepatitis C Vaccine Hampered by Viral Complexity, Many Technical Restraints". JNCI Journal of the National ... A hepatitis C vaccine, a vaccine capable of protecting against hepatitis C, is not available. Although vaccines exist for ... Development of a hepatitis C vaccine for horses most likely will bringing us closer to a vaccine against hepatitis C for humans ... hepatitis A and hepatitis B, development of a hepatitis C vaccine has presented challenges. No vaccine is currently available, ...
*  Ronald C. Kennedy
Kennedy, R.; Eichberg, J.; Lanford, R.; Dreesman, G. (1986). "Anti-idiotypic antibody vaccine for type B viral hepatitis in ... Kennedy has also helped to develop hepatitis B vaccines for chimpanzees and proposed their use in humans in a 1986 study. His ... Some of Kennedy's other research focused on the immune response to viral hepatitis. ... Kennedy was active in the search for an HIV vaccine for almost as long as the disease has existed. Kennedy has stated, "I first ...
*  Hayward Medical Communications
... disorders in practice Respiratory disease in practice Rheumatology in practice Thrombus Vaccines in practice Viral hepatitis in ...
*  HPV vaccines
Immunise Australia HPV Archived 2013-04-10 at the Wayback Machine.. 2011 Annual Surveillance Report of [[HIV, viral hepatitis, ... The vaccine is officially called the MEL-1 vaccine but also known as the MVA-E2 vaccine. In a study it has been suggested that ... Professor Ian Frazercreator of the HPV vaccine. "Human papillomavirus vaccine - New and underused vaccines support - Types of ... vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against ...
*  Genetically modified virus
... dengue fever and viral hepatitis by using a proven safe vaccine virus, such as adenovirus, and modify its genome to have genes ... Howarth, Joanna L.; Lee, Youn Bok; Uney, James B. (2010-2). "Using viral vectors as gene transfer tools (Cell Biology and ... In 2001, it was reported that genetically modified viruses can possibly be used to develop vaccines against diseases such as, ... Genetic modification involves the insertion or deletion of genes into the viral genome to improve organisms and is usually ...
*  Hepatitis A vaccine
Inactivated hepatitis A virus produced in MRC-5 cells. Each adult dose contains 1440 ELISA units of viral antigen adsorbed on ... Twinrix is a vaccine against hepatitis A and hepatitis B. Vivaxim is a vaccine against hepatitis A and typhoid. "WHO position ... A few formulations combine hepatitis A with either hepatitis B or typhoid vaccine. The first hepatitis A vaccine was approved ... Hepatitis A vaccine is a vaccine that prevents hepatitis A. It is effective in around 95% of cases and lasts for at least ...
*  Dermot P. Kelleher
Characterisation of immunogenetics of Hepatitis C viral clearance. Irish Society of Gastroenterology Irish Society for ... Vaccine development for H. pylori infection. Immunogenetics of gastrointestinal and liver disease. In 2004, he co-founded ... Development and patenting of H. pylori vaccine, which has been licensed to Chiron Corporation. ...
*  Global HIV Vaccine Enterprise
International AIDS Vaccine Initiative, French National Agency for Research on AIDS and Viral Hepatitis. In June 2003, a group ... The article asserted that current attempts to develop such a vaccine were insufficient and that a renewed HIV vaccine research ... Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise (2005) The Global HIV/AIDS Vaccine Enterprise: Scientific ... 18 January 2005 Global HIV/AIDS Vaccine Enterprise (2005). "The Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan ...
*  Merck & Co.
"1981-Hepatitis B: First Subunit Viral Vaccine in U.S". "3/17/1995-Chickenpox Vaccine Licensed". Beyer KH (1993). " ... Hilleman also developed the first Hepatitis B vaccine and the first varicella vaccine, for chickenpox. The thiazide diuretics ... "www.accessdata.fda.gov" (PDF). "Mumps - History of Vaccines". "Rubella - History of Vaccines". "1971-MMR Combination Vaccine ... Medically important vaccines developed at Merck include the first mumps vaccine, the first rubella vaccine, and the first ...
*  Leeuwenhoek Lecture
1985 Kenneth Murray, A molecular biologist's view of viral hepatitis 1984 William Duncan Paterson Stewart, The functional ... 1983 Michael Anthony Epstein, A prototype vaccine to prevent Epstein-Barr (E.B.) virus-associated tumours. 1982 Hamao Umezawa, ... Peptide vaccines, dream or reality. 1992 John Postgate, Bacterial evolution and the nitrogen-fixing plant 1991 Harry Smith, The ... Viral functions 1959 Frederick Charles Bawden, Viruses: retrospect and prospect 1958 David Keilin, The problem of anabiosis or ...
*  Oncovirus
... cancers due to a huge burden of viral hepatitis transmission and disease. Through advances in cancer research, vaccines ... which already carry the viral oncogene. Hepatitis viruses, including hepatitis B and hepatitis C, can induce a chronic viral ... The hepatitis B vaccine is the first vaccine that has been established to prevent cancer (hepatocellular carcinoma) by ... of hepatitis C carriers per year. Liver cirrhosis, whether from chronic viral hepatitis infection or alcoholism, is associated ...
*  E2 (HCV)
E2 is a viral structural protein found in the hepatitis C virus. It is present on the viral membrane and functions as a host ... It is a key target for the design of entry inhibitors and vaccine immunogens. Garcia JE, Puentes A, Súarez J, López R, Vera R, ... Bartosch B, Dubuisson J, Cosset FL (2003). "Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope ... Rodríguez LE, Ocampo M, Curtidor H, Guzman F, Urquiza M, Patarroyo ME (2002). "Hepatitis C virus (HCV) E1 and E2 protein ...
*  World Hepatitis Day
... screening and control of viral hepatitis and its related diseases; Increasing hepatitis B vaccine coverage and integration into ... 2014: Hepatitis: Think Again 2015: Prevention of viral Hepatitis. Act now. 2016: Know Hepatitis-Act now. 2017: Eliminate ... World Health Organization World Hepatitis Day, World Hepatitis Alliance World Hepatitis Day, Hepatitis C Trust UK. ... World Hepatitis Alliance, World Hepatitis Day Wrap-Up Report 2012. "World Hepatitis Day 2015 to focus on prevention". World ...
*  List of MeSH codes (D20)
... viral hepatitis vaccines MeSH D20.215.894.899.955.395 --- hepatitis a vaccines MeSH D20.215.894.899.955.400 --- hepatitis b ... vaccines, edible MeSH D20.215.894.865.940 --- vaccines, virosome MeSH D20.215.894.899 --- viral vaccines MeSH D20.215.894.899. ... measles vaccine MeSH D20.215.894.899.404.500 --- measles-mumps-rubella vaccine MeSH D20.215.894.899.488 --- mumps vaccine MeSH ... rubella vaccine MeSH D20.215.894.899.779.500 --- measles-mumps-rubella vaccine MeSH D20.215.894.899.790 --- saids vaccines MeSH ...
*  Services Hospital
Major effort is made to control major communicable diseases such as Tuberculosis, Malaria, viral Hepatitis B and C, HIV/AIDS ... diarrhea or vaccine-preventable illnesses. ...
*  RG7795
Funk, E; Kottilil, S; Gilliam, B; Talwani, R (14 May 2014). "Tickling the TLR7 to cure viral hepatitis". Journal of ... "Inovio Goes It Alone on Hepatitis B Immunotherapy Vaccine as Roche Ends Collaboration". Genetic Engineering News. August 3, ... RG7795 (ANA773 previously) is an antiviral drug candidate that as of 2015 had been in Phase II trials in hepatitis B. It is an ...
*  Hepatitis B
"Hepatitis B vaccine". Lancet. 2 (8206): 1229-1230. December 1980. doi:10.1016/S0140-6736(80)92484-8. PMID 6108398. "Viral ... when combined with hepatitis B immunoglobulin and the hepatitis B vaccine, especially for pregnant women with high hepatitis B ... Acute infection with hepatitis B virus is associated with acute viral hepatitis, an illness that begins with general ill-health ... Kramvis A, Kew M, François G (March 2005). "Hepatitis B virus genotypes". Vaccine. 23 (19): 2409-23. doi:10.1016/j.vaccine. ...
*  Hepatitis A
"Hepatitis A vaccines". Expert Rev Vaccines. 7 (5): 535-45. doi:10.1586/14760584.7.5.535. PMID 18564009. "Hepatitis A Vaccine: ... World Hepatitis Day occurs each year on July 28 to bring awareness to viral hepatitis. Early symptoms of hepatitis A infection ... It is one of five known hepatitis viruses: A, B, C, D, and E. The hepatitis A vaccine is effective for prevention. Some ... Vaccine. 28 (41): 6653-7. doi:10.1016/j.vaccine.2010.08.037. PMID 20723630. "Hepatitis A Information for Health Professionals ...
*  Hepatitis E
A vaccine based on recombinant viral proteins was developed in the 1990s and tested in a high-risk population (in Nepal) in ... Hepatitis E is a viral hepatitis (liver inflammation) caused by infection with a virus called hepatitis E virus. It is one of ... No hepatitis E vaccine is licensed for use in the United States. Although other HEV vaccine trials have been successful, these ... Hepatitis!E!Vaccine!Working!Group (2012). "Hepatitis(E:(epidemiology(and(disease(burden" (PDF). WHO. Retrieved 27 February 2016 ...
*  Dr. Ruth Pfau Hospital
Measures are also in place to prevent and control major communicable diseases such as Tuberculosis, Malaria, viral Hepatitis B ... diarrhea or vaccine-preventable illnesses. ...
*  HLA-A1
Some diseases found associated with A1 actually link to the extended A1-B8 haplotype, viral induced hepatitis and accelerated ... A more recent paper showed an association of A*0101 with lower than average responses to measles vaccine. With rubella, A1-B8 ... Hug G (May 1976). "Genetic factors and autoimmunity in viral hepatitis". Am. J. Clin. Pathol. 65 (5 Suppl): 870-5. PMID 218441 ...
*  Hepatitis B virus
J Viral Hepat doi: 10.1111/jvh.12631. Kramvis A, Kew M, François G (2005). "Hepatitis B virus genotypes". Vaccine. 23 (19): ... Non primate species included the woodchuck hepatitis virus, the ground squirrel hepatitis virus and arctic squirrel hepatitis ... the Ground squirrel hepatitis virus, Woodchuck hepatitis virus, and the Woolly monkey hepatitis B virus. The genus is ... Viral infection by hepatitis B virus (HBV) causes many hepatocyte changes due to direct action of a protein coded for by the ...
*  Interferon
"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance". Nature. 461 (7262): 399-401. Bibcode: ... For example, during research to produce a more efficient vaccine for smallpox, Yasu-ichi Nagano and Yasuhiko Kojima-two ... Both hepatitis B and hepatitis C are treated with IFN-α, often in combination with other antiviral drugs. Some of those treated ... Binding of molecules uniquely found in microbes-viral glycoproteins, viral RNA, bacterial endotoxin (lipopolysaccharide), ...
*  Gladstone Institutes
Looking for new biological targets for drugs that will attack the hepatitis C virus. Immunology of viral infection. Exploring ... preventing viral transmission of HIV with drugs or a vaccine for those at risk of coming in contact with the virus, curing the ... In addition, the group studies hepatitis C, HTLV and the immunology of viral infections. Current research programs include: " ... Using iPS technology to create a new model for testing a vaccine for HIV/AIDS. Translational Research The Gladstone Center for ...